| 发明名称 |
EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer |
| 摘要 |
<p>The application relates to a combination of biologically active compounds comprising at least one antiviral agent and at least one EGFR antagonist, for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of malignant or pre-malignant neoplasms, preferably of solid malignant or pre-malignant neoplasms.</p> |
| 申请公布号 |
EP2552452(B8) |
申请公布日期 |
2016.01.13 |
| 申请号 |
EP20110709746 |
申请日期 |
2011.03.24 |
| 申请人 |
INSTITUT GUSTAVE ROUSSY (IGR);UNIVERSITÉ PARIS-SUD 11 |
发明人 |
DEUTSCH, ERIC;VOZENIN, MARIE CATHERINE;BOURHIS, JEAN |
| 分类号 |
A61K31/675;A61K31/517;A61K31/522;A61K31/662;A61K39/395;A61K45/06;A61P35/00 |
主分类号 |
A61K31/675 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
